Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

(AVATAR) A Double-Blind, Randomized, Multicenter, Phase III Study of Bevacizumab in Combination With Capecitabine and Cisplatin Versus Placebo in Combination With Capecitabine and Cisplatin, as First-Line Therapy in Patients With Advanced Gastric Cancer.
bevacizumab
ML22367
NCT00887822
gastric cancer
Phase 3
 
June 2017

Powered by ideaPoint, Inc.